The expression of full length Gp91-phox protein is associated with reduced amphotropic retroviral production

Department of Immunology, Imperial College School of Medicine, The Hammersmith Hospital, Du Cane Road, London, W12 0NN, United Kingdom. i.bellantuono@ic.ac.uk BACKGROUND AND OBJECTIVE: As a single gene defect in mature bone marrow cells, chronic granulomatous disease (X-CGD) represents a disorder wh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Haematologica (Roma) 2000-05, Vol.85 (5), p.451-457
Hauptverfasser: Bellantuono, I, Lashford, LS, Rafferty, JA, Fairbairn, LJ
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 457
container_issue 5
container_start_page 451
container_title Haematologica (Roma)
container_volume 85
creator Bellantuono, I
Lashford, LS
Rafferty, JA
Fairbairn, LJ
description Department of Immunology, Imperial College School of Medicine, The Hammersmith Hospital, Du Cane Road, London, W12 0NN, United Kingdom. i.bellantuono@ic.ac.uk BACKGROUND AND OBJECTIVE: As a single gene defect in mature bone marrow cells, chronic granulomatous disease (X-CGD) represents a disorder which may be amenable to gene therapy by the transfer of the missing subunit into hemopoietic stem cells. In the majority of cases lack of Gp91-phox causes the disease. So far, studies involving transfer of Gp91-phox cDNA, including a phase I clinical trial, have yielded disappointing results. Most often, low titers of virus have been reported. In the present study we investigated the possible reasons for low titer amphotropic viral production. DESIGN AND METHODS: To investigate the effect of Gp91 cDNA on the efficiency of retroviral production from the packaging cell line, GP+envAm12, we constructed vectors containing either the native cDNA, truncated versions of the cDNA or a mutated form (LATG) in which the natural translational start codon was changed to a stop codon. Following derivation of clonal packaging cell lines, these were assessed for viral titer by RNA slot blot and analyzed by non-parametrical statistical analysis (Whitney-Mann U-test). RESULTS: An improvement in viral titer of just over two-fold was found in packaging cells containing the start-codon mutant of Gp91 and no evidence of truncated viral RNA was seen in these cells. Further analysis revealed the presence of rearranged forms of the provirus in Gp91-expressing cells, and the production of truncated, unpackaged viral RNA. Protein analysis revealed that LATG-transduced cells did not express full-length Gp91-phox, whereas those containing the wild-type cDNA did. However, a truncated protein was seen in ATG-transduced cells which was also present in wild type cells. No evidence for the presence of a negative transcriptional regulatory element was found from studies with the deletion mutants. INTERPRETATION AND CONCLUSIONS: A statistically significant effect of protein production on the production of virus from Gp91-expressing cells was found. Our data point to a need to restrict expression of the Gp91-phox protein and its derivatives in order to enhance retroviral production and suggest that improvements in current vectors for CGD gene therapy may need to include controlled, directed expression only in mature neutrophils.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71096884</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71096884</sourcerecordid><originalsourceid>FETCH-LOGICAL-h266t-7b6467f7ba06081d5c2ac61287b3cfde58cf120f2fe7cc3242b77de8d121906e3</originalsourceid><addsrcrecordid>eNpF0M9PwyAUB3BiNG5O_wXDQb01AdoCPZpFp8kSL_PcUPpYMfSH0Nr534vZjKf3gM_7krwztKR5wRIpGD1HS5IWJOFEyAW6CuGDEEaKQlyiBSWSEJrLJXK7BjAcBg8h2L7DvcFmcg476PZjgzdDQZOh6Q948P0ItsM2YBVCr60aocazjchDPel4UG2Uo-8Hq-NdbL6sV-53Mr6PMf0aXRjlAtyc6gq9Pz_t1i_J9m3zun7cJg3jfExExTMujKgU4UTSOtdMaU6ZFFWqTQ251IYyYpgBoXXKMlYJUYOsKaMF4ZCu0MMxN379OUEYy9YGDc6pDvoplIKSgkuZRXh7glPVQl0O3rbKf5d_-4ng7gRU0MoZrzptw7_LKOWpiOz-yBq7b2broQytci6msnKeZ5mXeZnlNP0BjyF-Fg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71096884</pqid></control><display><type>article</type><title>The expression of full length Gp91-phox protein is associated with reduced amphotropic retroviral production</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><creator>Bellantuono, I ; Lashford, LS ; Rafferty, JA ; Fairbairn, LJ</creator><creatorcontrib>Bellantuono, I ; Lashford, LS ; Rafferty, JA ; Fairbairn, LJ</creatorcontrib><description>Department of Immunology, Imperial College School of Medicine, The Hammersmith Hospital, Du Cane Road, London, W12 0NN, United Kingdom. i.bellantuono@ic.ac.uk BACKGROUND AND OBJECTIVE: As a single gene defect in mature bone marrow cells, chronic granulomatous disease (X-CGD) represents a disorder which may be amenable to gene therapy by the transfer of the missing subunit into hemopoietic stem cells. In the majority of cases lack of Gp91-phox causes the disease. So far, studies involving transfer of Gp91-phox cDNA, including a phase I clinical trial, have yielded disappointing results. Most often, low titers of virus have been reported. In the present study we investigated the possible reasons for low titer amphotropic viral production. DESIGN AND METHODS: To investigate the effect of Gp91 cDNA on the efficiency of retroviral production from the packaging cell line, GP+envAm12, we constructed vectors containing either the native cDNA, truncated versions of the cDNA or a mutated form (LATG) in which the natural translational start codon was changed to a stop codon. Following derivation of clonal packaging cell lines, these were assessed for viral titer by RNA slot blot and analyzed by non-parametrical statistical analysis (Whitney-Mann U-test). RESULTS: An improvement in viral titer of just over two-fold was found in packaging cells containing the start-codon mutant of Gp91 and no evidence of truncated viral RNA was seen in these cells. Further analysis revealed the presence of rearranged forms of the provirus in Gp91-expressing cells, and the production of truncated, unpackaged viral RNA. Protein analysis revealed that LATG-transduced cells did not express full-length Gp91-phox, whereas those containing the wild-type cDNA did. However, a truncated protein was seen in ATG-transduced cells which was also present in wild type cells. No evidence for the presence of a negative transcriptional regulatory element was found from studies with the deletion mutants. INTERPRETATION AND CONCLUSIONS: A statistically significant effect of protein production on the production of virus from Gp91-expressing cells was found. Our data point to a need to restrict expression of the Gp91-phox protein and its derivatives in order to enhance retroviral production and suggest that improvements in current vectors for CGD gene therapy may need to include controlled, directed expression only in mature neutrophils.</description><identifier>ISSN: 0390-6078</identifier><identifier>EISSN: 1592-8721</identifier><identifier>PMID: 10800158</identifier><language>eng</language><publisher>Pavia: Haematologica</publisher><subject>3T3 Cells ; Animals ; Biological and medical sciences ; Blotting, Northern ; Blotting, Southern ; Blotting, Western ; DNA, Complementary - genetics ; Gene Transfer Techniques - standards ; Genetic Vectors - chemistry ; Humans ; Immunodeficiencies ; Immunodeficiencies. Immunoglobulinopathies ; Immunopathology ; Medical sciences ; Membrane Glycoproteins - genetics ; Membrane Glycoproteins - pharmacology ; Mice ; NADPH Oxidase 2 ; NADPH Oxidases ; Retroviridae - drug effects ; Retroviridae - genetics ; Retroviridae - growth &amp; development ; RNA, Viral - biosynthesis ; Viral Proteins - analysis</subject><ispartof>Haematologica (Roma), 2000-05, Vol.85 (5), p.451-457</ispartof><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1411637$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10800158$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bellantuono, I</creatorcontrib><creatorcontrib>Lashford, LS</creatorcontrib><creatorcontrib>Rafferty, JA</creatorcontrib><creatorcontrib>Fairbairn, LJ</creatorcontrib><title>The expression of full length Gp91-phox protein is associated with reduced amphotropic retroviral production</title><title>Haematologica (Roma)</title><addtitle>Haematologica</addtitle><description>Department of Immunology, Imperial College School of Medicine, The Hammersmith Hospital, Du Cane Road, London, W12 0NN, United Kingdom. i.bellantuono@ic.ac.uk BACKGROUND AND OBJECTIVE: As a single gene defect in mature bone marrow cells, chronic granulomatous disease (X-CGD) represents a disorder which may be amenable to gene therapy by the transfer of the missing subunit into hemopoietic stem cells. In the majority of cases lack of Gp91-phox causes the disease. So far, studies involving transfer of Gp91-phox cDNA, including a phase I clinical trial, have yielded disappointing results. Most often, low titers of virus have been reported. In the present study we investigated the possible reasons for low titer amphotropic viral production. DESIGN AND METHODS: To investigate the effect of Gp91 cDNA on the efficiency of retroviral production from the packaging cell line, GP+envAm12, we constructed vectors containing either the native cDNA, truncated versions of the cDNA or a mutated form (LATG) in which the natural translational start codon was changed to a stop codon. Following derivation of clonal packaging cell lines, these were assessed for viral titer by RNA slot blot and analyzed by non-parametrical statistical analysis (Whitney-Mann U-test). RESULTS: An improvement in viral titer of just over two-fold was found in packaging cells containing the start-codon mutant of Gp91 and no evidence of truncated viral RNA was seen in these cells. Further analysis revealed the presence of rearranged forms of the provirus in Gp91-expressing cells, and the production of truncated, unpackaged viral RNA. Protein analysis revealed that LATG-transduced cells did not express full-length Gp91-phox, whereas those containing the wild-type cDNA did. However, a truncated protein was seen in ATG-transduced cells which was also present in wild type cells. No evidence for the presence of a negative transcriptional regulatory element was found from studies with the deletion mutants. INTERPRETATION AND CONCLUSIONS: A statistically significant effect of protein production on the production of virus from Gp91-expressing cells was found. Our data point to a need to restrict expression of the Gp91-phox protein and its derivatives in order to enhance retroviral production and suggest that improvements in current vectors for CGD gene therapy may need to include controlled, directed expression only in mature neutrophils.</description><subject>3T3 Cells</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Blotting, Northern</subject><subject>Blotting, Southern</subject><subject>Blotting, Western</subject><subject>DNA, Complementary - genetics</subject><subject>Gene Transfer Techniques - standards</subject><subject>Genetic Vectors - chemistry</subject><subject>Humans</subject><subject>Immunodeficiencies</subject><subject>Immunodeficiencies. Immunoglobulinopathies</subject><subject>Immunopathology</subject><subject>Medical sciences</subject><subject>Membrane Glycoproteins - genetics</subject><subject>Membrane Glycoproteins - pharmacology</subject><subject>Mice</subject><subject>NADPH Oxidase 2</subject><subject>NADPH Oxidases</subject><subject>Retroviridae - drug effects</subject><subject>Retroviridae - genetics</subject><subject>Retroviridae - growth &amp; development</subject><subject>RNA, Viral - biosynthesis</subject><subject>Viral Proteins - analysis</subject><issn>0390-6078</issn><issn>1592-8721</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpF0M9PwyAUB3BiNG5O_wXDQb01AdoCPZpFp8kSL_PcUPpYMfSH0Nr534vZjKf3gM_7krwztKR5wRIpGD1HS5IWJOFEyAW6CuGDEEaKQlyiBSWSEJrLJXK7BjAcBg8h2L7DvcFmcg476PZjgzdDQZOh6Q948P0ItsM2YBVCr60aocazjchDPel4UG2Uo-8Hq-NdbL6sV-53Mr6PMf0aXRjlAtyc6gq9Pz_t1i_J9m3zun7cJg3jfExExTMujKgU4UTSOtdMaU6ZFFWqTQ251IYyYpgBoXXKMlYJUYOsKaMF4ZCu0MMxN379OUEYy9YGDc6pDvoplIKSgkuZRXh7glPVQl0O3rbKf5d_-4ng7gRU0MoZrzptw7_LKOWpiOz-yBq7b2broQytci6msnKeZ5mXeZnlNP0BjyF-Fg</recordid><startdate>20000501</startdate><enddate>20000501</enddate><creator>Bellantuono, I</creator><creator>Lashford, LS</creator><creator>Rafferty, JA</creator><creator>Fairbairn, LJ</creator><general>Haematologica</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20000501</creationdate><title>The expression of full length Gp91-phox protein is associated with reduced amphotropic retroviral production</title><author>Bellantuono, I ; Lashford, LS ; Rafferty, JA ; Fairbairn, LJ</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h266t-7b6467f7ba06081d5c2ac61287b3cfde58cf120f2fe7cc3242b77de8d121906e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>3T3 Cells</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Blotting, Northern</topic><topic>Blotting, Southern</topic><topic>Blotting, Western</topic><topic>DNA, Complementary - genetics</topic><topic>Gene Transfer Techniques - standards</topic><topic>Genetic Vectors - chemistry</topic><topic>Humans</topic><topic>Immunodeficiencies</topic><topic>Immunodeficiencies. Immunoglobulinopathies</topic><topic>Immunopathology</topic><topic>Medical sciences</topic><topic>Membrane Glycoproteins - genetics</topic><topic>Membrane Glycoproteins - pharmacology</topic><topic>Mice</topic><topic>NADPH Oxidase 2</topic><topic>NADPH Oxidases</topic><topic>Retroviridae - drug effects</topic><topic>Retroviridae - genetics</topic><topic>Retroviridae - growth &amp; development</topic><topic>RNA, Viral - biosynthesis</topic><topic>Viral Proteins - analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bellantuono, I</creatorcontrib><creatorcontrib>Lashford, LS</creatorcontrib><creatorcontrib>Rafferty, JA</creatorcontrib><creatorcontrib>Fairbairn, LJ</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Haematologica (Roma)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bellantuono, I</au><au>Lashford, LS</au><au>Rafferty, JA</au><au>Fairbairn, LJ</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The expression of full length Gp91-phox protein is associated with reduced amphotropic retroviral production</atitle><jtitle>Haematologica (Roma)</jtitle><addtitle>Haematologica</addtitle><date>2000-05-01</date><risdate>2000</risdate><volume>85</volume><issue>5</issue><spage>451</spage><epage>457</epage><pages>451-457</pages><issn>0390-6078</issn><eissn>1592-8721</eissn><abstract>Department of Immunology, Imperial College School of Medicine, The Hammersmith Hospital, Du Cane Road, London, W12 0NN, United Kingdom. i.bellantuono@ic.ac.uk BACKGROUND AND OBJECTIVE: As a single gene defect in mature bone marrow cells, chronic granulomatous disease (X-CGD) represents a disorder which may be amenable to gene therapy by the transfer of the missing subunit into hemopoietic stem cells. In the majority of cases lack of Gp91-phox causes the disease. So far, studies involving transfer of Gp91-phox cDNA, including a phase I clinical trial, have yielded disappointing results. Most often, low titers of virus have been reported. In the present study we investigated the possible reasons for low titer amphotropic viral production. DESIGN AND METHODS: To investigate the effect of Gp91 cDNA on the efficiency of retroviral production from the packaging cell line, GP+envAm12, we constructed vectors containing either the native cDNA, truncated versions of the cDNA or a mutated form (LATG) in which the natural translational start codon was changed to a stop codon. Following derivation of clonal packaging cell lines, these were assessed for viral titer by RNA slot blot and analyzed by non-parametrical statistical analysis (Whitney-Mann U-test). RESULTS: An improvement in viral titer of just over two-fold was found in packaging cells containing the start-codon mutant of Gp91 and no evidence of truncated viral RNA was seen in these cells. Further analysis revealed the presence of rearranged forms of the provirus in Gp91-expressing cells, and the production of truncated, unpackaged viral RNA. Protein analysis revealed that LATG-transduced cells did not express full-length Gp91-phox, whereas those containing the wild-type cDNA did. However, a truncated protein was seen in ATG-transduced cells which was also present in wild type cells. No evidence for the presence of a negative transcriptional regulatory element was found from studies with the deletion mutants. INTERPRETATION AND CONCLUSIONS: A statistically significant effect of protein production on the production of virus from Gp91-expressing cells was found. Our data point to a need to restrict expression of the Gp91-phox protein and its derivatives in order to enhance retroviral production and suggest that improvements in current vectors for CGD gene therapy may need to include controlled, directed expression only in mature neutrophils.</abstract><cop>Pavia</cop><pub>Haematologica</pub><pmid>10800158</pmid><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0390-6078
ispartof Haematologica (Roma), 2000-05, Vol.85 (5), p.451-457
issn 0390-6078
1592-8721
language eng
recordid cdi_proquest_miscellaneous_71096884
source MEDLINE; DOAJ Directory of Open Access Journals
subjects 3T3 Cells
Animals
Biological and medical sciences
Blotting, Northern
Blotting, Southern
Blotting, Western
DNA, Complementary - genetics
Gene Transfer Techniques - standards
Genetic Vectors - chemistry
Humans
Immunodeficiencies
Immunodeficiencies. Immunoglobulinopathies
Immunopathology
Medical sciences
Membrane Glycoproteins - genetics
Membrane Glycoproteins - pharmacology
Mice
NADPH Oxidase 2
NADPH Oxidases
Retroviridae - drug effects
Retroviridae - genetics
Retroviridae - growth & development
RNA, Viral - biosynthesis
Viral Proteins - analysis
title The expression of full length Gp91-phox protein is associated with reduced amphotropic retroviral production
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T19%3A59%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20expression%20of%20full%20length%20Gp91-phox%20protein%20is%20associated%20with%20reduced%20amphotropic%20retroviral%20production&rft.jtitle=Haematologica%20(Roma)&rft.au=Bellantuono,%20I&rft.date=2000-05-01&rft.volume=85&rft.issue=5&rft.spage=451&rft.epage=457&rft.pages=451-457&rft.issn=0390-6078&rft.eissn=1592-8721&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E71096884%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71096884&rft_id=info:pmid/10800158&rfr_iscdi=true